Filing Details

Accession Number:
0001209191-16-116574
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-29 21:00:35
Reporting Period:
2016-04-29
Filing Date:
2016-04-29
Accepted Time:
2016-04-29 21:00:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578823 T Ryan Sullivan C/o Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Evp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-29 3,125 $66.33 30,132 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.